Profile
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Stefan Glombitza active positions
| Companies | Position | Start |
|---|---|---|
| FORMYCON AG | Chief Executive Officer | 2022-06-30 |
Former positions of Stefan Glombitza
| Companies | Position | End |
|---|---|---|
Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
Training of Stefan Glombitza
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
University of Regensburg
University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Formycon AG
Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Hexal Pharmaforschung GmbH |
- Stock Market
- Insiders
- Stefan Glombitza
















